Skip to main content
. 2019 May 15;11(5):2775–2783.

Figure 1.

Figure 1

Sitagliptin ameliorates advanced glycation end-products (AGEs)-induced oxidative stress in human primary chondrocytes. Human primary chondrocytes were treated with 100 μg/ml AGEs in the presence or absence of 100, 200 nM sitagliptin for 48 h. A. Reactive oxygen species (ROS) was determined by DCFH-DA; B. Intracellular level of reduced GSH (a, b, c, P<0.01 vs. previous column group).